Citation: Ku. Kirchgassler et al., EFFECTIVENESS AND TOLERABILITY OF 12-WEEK TREATMENT WITH MICRONIZED FENOFIBRATE 200MG IN A DRUG-MONITORING PROGRAM INVOLVING 9884 PATIENTS WITH DYSLIPIDEMIA, Clinical drug investigation, 15(3), 1998, pp. 197-204
Authors:
KIRCHGASSLER KU
SCHIFFNERROHE J
STAHLHEBER U
Citation: Ku. Kirchgassler et al., COST-EFFECTIVENESS OF MICRONIZED FENOFIBRATE AND SIMVASTATIN IN THE SHORT-TERM TREATMENT OF TYPE IIA AND TYPE IIB HYPERLIPIDEMIA, PharmacoEconomics, 12(2), 1997, pp. 237-246
Citation: Ku. Kirchgassler et al., CROSS-COUNTRY ADAPTATION OF PHARMACO-ECONOMIC EVALUATIONS - THE EXAMPLE OF MICRONIZED FENOFIBRATE AND SIMVASTATIN, Atherosclerosis, 134(1-2), 1997, pp. 52-52